Go back

Biotech business explores mRNA vaccine production in West Africa


Senegal and Rwanda set to benefit from partnership with Germany’s BioNTech

Germany-based biotechnology company BioNTech is exploring plans to set up vaccine manufacturing capabilities in West Africa to produce cutting-edge mRNA vaccines.

The company announced the plans in a joint communique on 27 August after meeting the presidents of Rwanda and Senegal, Paul Kagame and Macky Sall, as well as European Commission president Ursula von der Leyen.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.